INTERNATIONAL PATENT: VEVO THERAPEUTICS, INC. FILES APPLICATION FOR "MEK INHIBITORS, ALONE OR IN COMBINATION WITH CDK4/5 INHIBITORS, FOR USE IN TREATING CANCER"

GENEVA, May 7 -- VEVO THERAPEUTICS, INC. (681 Gateway Blvd.South San Francisco, CA, 94080) filed a patent application (PCT/US2024/053119) for "MEK INHIBITORS, ALONE OR IN COMBINATION WITH CDK4/5 INHIBITORS, FOR USE IN TREATING CANCER" on Oct 25, 2024. With publication no. WO/2025/090966, the details related to the patent application was published on May 01, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): YU, John (681 Gateway Blvd.South San Francisco, CA, 94080), TOUTOUNCHIAN, Jordan (681 Gateway Blvd.South San Francisco, CA, 94080), MERICO, Daniele (681 Gateway Blvd.South San Francisco, CA,...